PSCC Innovation Forum 2024

5 Feb 2024 | Le Kremlin Bicêtre, France

Karine ROSSIGNOL

CEO and co-founder of Smart Immune

Smart Immune

Paris, France

24 profile visitsSpeakerParticipant

Before co-founding Smart Immune in 2017, I was the CEO of the French Foundation for Hearing and the co-secretary general of the Imagine Institute for 10 years.

My organisation

SMART IMMUNE

SMART IMMUNE

Start-up, Biotech, Medtech, Deeptech

Paris, France

Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T cell progenitor therapy platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The company aims to radically improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is already in Phase I/II clinical trials, in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The Company is headquartered in Paris, France, at Paris Biotech Santé.
Read more

About me

Karine has a strong track record of 30 years in industry and biomedical research institutes. As a Doctor of Pharmacy and a HEC Business School graduate, she brings extensive managing experience in the public and private sectors. Before co-founding Smart Immune, she was the CEO of the French Foundation for Hearing for 3 years and the co-secretary general of the Imagine Institute of Genetic Diseases for 10 years, where she structured, developed, and ensured fundraising for the institute. She also has 15 years of experience at LVMH, L’Oréal, and Chanel where she deepened her international marketing expertise before earning a master’s degree in genetics.

My organisation

Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T cell progenitor therapy platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The company aims to radically improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is already in Phase I/II clinical trials, in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its ProTcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The Company is headquartered in Paris, France, at Paris Biotech Santé.

Social media

Skills

  • biotechnology
  • Business
  • Fundraising
  • Strategy
  • pharmaceutical industry
  • large-scale operations
  • Management

Interests

  • cancer
  • Innnovation
  • cell therapy
  • thymus
  • CAR T cells
  • Investment
  • T cells
  • biotechnology
  • partnerships

Additional questions

Interested in HR networking ?

Hiring

Speaker sessions (1)

Monday, 5 February 2024

18:00 - 18:40